Author

M. Bourgey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:ChIP-seq· 1 Research Focus:clustering· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Bousfiha· 1 shared A. Puel· 1 shared B. Misic· 1 shared C. A. Croft· 1 shared C. Gruber· 1 shared C. Lee· 1 shared C. Ma· 1 shared C. Oleaga-Quintas· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Bousfiha

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Human T-bet governs innate and innate-like adaptive IFN-γ immunity against mycobacteria

R. Yang, F. Mele, L. Worley, D. Langlais, J. Rosain, I. Benhsaien, H. Elarabi, C. A. Croft, J.-M. Doisne, P. Zhang, M. Weisshaar, D. Jarrossay, D. Latorre, Y. Shen, J. Han, , L. H Glimcher

This study identifies T-bet deficiency as a cause of mycobacterial disease by impairing IFN-γ production in innate and innate-like adaptive lymphocytes.

bioRxiv · Aug 31, 2020Immunology

Single-cell RNA-seq reveals that glioblastoma recapitulates normal brain development

C. P. Couturier, S. Ayyadhury, P. U. Le, J. Monlong, G. Riva, R. Allache, S. Baig, X. Yan, M. Bourgey, C. Lee, Y. C. D. Wang, V. W. Yong, M.-C. Guiot, B. Misic, J. Antel, , K. Petrecca

The paper uses single-cell RNA-seq to show glioblastoma recapitulates normal brain development, identifying a conserved trilineage hierarchy with glial progenitor-like cells as the origin of cancer heterogeneity and therapeutic targets.

bioRxiv · Oct 22, 2018 · PreprintCancer Biology